MedPath

The effects of resistance exercise and training with blood flow restriction on platelet-activating factors

Not Applicable
Conditions
Type 2 diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20130901014540N2
Lead Sponsor
, Shahid Beheshti University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
75
Inclusion Criteria

Patients with type 2 diabetes should not have heart disease, including ischemic heart disease including MI, angina, arrhythmia, heart failure, valvular disease, and abnormal ECG. These patients should not take more than two types of medication at the same time and should not take insulin. Patients should not take antiplatelet drugs such as aspirin, NSAIDs, and Clopidogrel, have no history of regular exercise, have not performed resistance training in the last six months, and do not have joint disease.

Exclusion Criteria

History of specific infectious and immune diseases, smoking, consumption of alcoholic beverages, dietary supplements and anti-inflammatory drugs, muscle damage and damage to the knee and pelvic joints are the most important factors in the withdrawal of subjects in this research project. Patients with tissue or joint injuries following resistance training are excluded from the research plan.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Platelet-activating factors. Timepoint: At the beginning of the study, immediately and 30 minutes after the activity. Method of measurement: Flow cytometry is used to measure P-selectin, GpIIb / IIIa.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath